Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis
✍ Scribed by Patrick Garnero; Xavier Ayral; Jean-Charles Rousseau; S. Christgau; Linda J. Sandell; Maxime Dougados; Pierre D. Delmas
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 166 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To investigate in a randomized clinical trial setting with an aggressive combination‐therapy arm and a mild‐monotherapy arm, whether therapy‐induced changes in urinary C‐terminal crosslinking telopeptide of type I collagen (CTX‐I) and type II collagen (CTX‐II) predict 5‐ye
## Abstract ## Objective Bisphosphonates have slowed the progression of osteoarthritis (OA) in animal models and have decreased pain in states of high bone turnover. The Knee OA Structural Arthritis (KOSTAR) study, which is the largest study to date investigating a potential structure‐modifying OA